Revolutionizing healthy ageing: ARPA-H's bold new initiative
Advanced Research Projects Agency for Health (ARPA-H) - 19-Dec-2024Extending healthspan and tackling age-related challenges with innovative therapies and technologies
Join the club for FREE to access the whole archive and other member benefits.
Research funding agency that supports transformative biomedical and health breakthroughs
The Advanced Research Projects Agency for Health (ARPA-H) supports the development of high-impact research to drive biomedical and health breakthroughs to deliver transformative, sustainable, and equitable health solutions for everyone.*ARPA-H’s mission focuses on leveraging research advances for real world impact.
ARPA-H advances high-potential, high-impact biomedical and health research that cannot be readily accomplished through traditional research or commercial activity. ARPA-H awardees are developing entirely new ways to tackle the hardest challenges in health. The ARPA model enables visionary Program Managers to tackle a specific problem, working with a range of performers and a variety of approaches to solve that problem, while incorporating measurement and evaluation throughout the process. Program Managers serve for limited terms to ensure a constant infusion of fresh thinking and new perspectives.
Visit website: https://arpa-h.gov/
See also: National Institutes of Health (NIH) - Medical research agency that supports scientific studies
Details last updated 03-Oct-2023
Extending healthspan and tackling age-related challenges with innovative therapies and technologies
Cutting-edge AI and laser technology will scale production of personalized regenerative medicines
A groundbreaking approach to extend life through brain tissue renewal
Personalized bioprints for affordable and more accessible transplants in the near future
The project harnesses cutting-edge science to reconnect the eye to the brain
This may improve immune function for those with thymus disorders and immune decline
Implant continuously monitors cancer and adjusts immunotherapy dose in real time